US20030086877A1 - Devices, compositions and methods for the pulmonary delivery of aerosolized medicaments - Google Patents

Devices, compositions and methods for the pulmonary delivery of aerosolized medicaments Download PDF

Info

Publication number
US20030086877A1
US20030086877A1 US10/245,705 US24570502A US2003086877A1 US 20030086877 A1 US20030086877 A1 US 20030086877A1 US 24570502 A US24570502 A US 24570502A US 2003086877 A1 US2003086877 A1 US 2003086877A1
Authority
US
United States
Prior art keywords
composition
dry powder
μm
pharmaceutical
particle size
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US10/245,705
Inventor
Robert Platz
John Patton
Linda Foster
Mohammed Eljamal
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis Pharma AG
Original Assignee
Nektar Therapeutics
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to US07/910,048 priority Critical patent/US5458135A/en
Priority to US4435893A priority
Priority to US08/232,849 priority patent/US5607915A/en
Priority to US24603494A priority
Priority to US08/309,691 priority patent/US5785049A/en
Priority to US31370794A priority
Priority to US38347595A priority
Priority to US41750795A priority
Priority to US08/423,515 priority patent/US6582728B1/en
Priority to US09/427,075 priority patent/US6509006B1/en
Priority to US09/447,753 priority patent/US6372258B1/en
Priority to US09/616,236 priority patent/US6673335B1/en
Application filed by Nektar Therapeutics filed Critical Nektar Therapeutics
Priority to US10/245,705 priority patent/US20030086877A1/en
Assigned to NEKTAR THERAPEUTICS reassignment NEKTAR THERAPEUTICS CHANGE OF NAME (SEE DOCUMENT FOR DETAILS). Assignors: INHALE THERAPEUTIC SYSTEMS, INC.
Publication of US20030086877A1 publication Critical patent/US20030086877A1/en
Assigned to NOVARTIS PHARMA AG reassignment NOVARTIS PHARMA AG ASSIGNMENT OF PATENT RIGHTS Assignors: NEKTAR THERAPEUTICS
Application status is Abandoned legal-status Critical

Links